Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial

  • Elevated Endotoxin level
  • Company: Optimal Balance Pharmacy
  • Drugs
  • FDA
  • August 19, 2026

Product details

  • Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial

Company announcement

Optimal Balance Pharmacy is voluntarily recalling one lot of Compounded Glutathione 200 MG/ML 30 ML Multi-Dose Vials.

The recall was initiated because pharmacy testing identified elevated bacterial endotoxin levels.

The product was distributed to consumers in Arizona, Colorado, Florida, Illinois, Louisiana, Michigan, New York, Nevada, Oklahoma, Pennsylvania, Texas, Utah, Vermont, and Washington.

Adverse events reported include fever, chills, severe headache, nausea, vomiting, pain, and symptoms consistent with an allergic reaction. No deaths have been reported.

The recall was announced on August 19, 2026.

Risk:

There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death.

Impacted states: Nationwide

Products:

- Glutathione Injection 200MG/ML (30ML) Multi-Dose Vial

Contact

For more information, call (218) 919-2964.

View the original FDA notice

Browse all recalls

Related recalls